First Public Offering of Shares of Borui Biopharmaceuticals (Suzhou) Co., Ltd. and Application for Listing on the Sci-Tech Innovation Board

Borui Biopharmaceuticals (Suzhou) Co., Ltd. is a biopharmaceutical company that mainly engages in the R&D, production and sales of innovative drugs. The company's core products include: 1) Recombinant Human Coagulation Factor VIII for Injection; 2) Recombinant Human Coagulation Factor IX for Injection; 3) Human Serum Albumin for Injection; 4) Human Immunoglobulin Injection.


File format
PDF
Published
17 November, 2023
Updated
17 November, 2023
MD5 checksum
6B181B7DF033FD50F6E9E1B1CD7DD119
Download PDF

Also Manuals